Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Lung Cancer Treatment

Trial Shows Novel Vaccine’s Potential for Lung Cancer Treatment

Posted on September 25, 2023
Post Views: 339

Lung Cancer TreatmentA new vaccine has shown to improve survival rate among people suffering from lung cancer. A French biotechnology company said that Ose Immunotherapeutics’ Tedopi vaccine was effective in decreasing death risk among lung cancer patients by 41%. This vaccine was administrated to patients with advanced non-small cell lung cancer which is the most common type of lung cancer. Also, it is usually less sensitive to radiation therapy and chemotherapy. In this trial, a total of 219 patients took part in nine European countries and the United States. Of these, 139 patients received the vaccine and 80 received chemotherapy.

In this study, they found that those who received Tedopi shoed significantly higher survival rates and better quality of life as compared to those who received chemotherapy. Professor Benjamin Besse from the Gustave Roussy Institute, said in a statement, “A significant 41% reduction in the risk of death was observed, associated with an improved tolerance score and maintained quality of life.” “Further evaluation is clearly warranted in a second line of treatment of advanced and metastatic NSCLC, to potentially make this cancer vaccine available to hard-to-treat patients in failure and with high medical needs,” Besse added.

Study: Avastin Copycat ABP 215 Found Helpful In Lung CancerThe overall survival rate with Tedopi at one year was 44.4% in comparison to 27.5% with chemotherapy. They also found a clinically meaningful benefit in median overall survival of 3.6 months in patients who received the vaccine. Also, post progression survival was significantly greater in length for Tedopi: 7.7 months in comparison with 4.6 months for chemotherapy.

This vaccine trial was used as a third-line treatment which means that the patients had already received two other therapies. The Tedopi vaccine is effective in patients with the HLA-A2 gene, which is present in about half the population, as per Ose Immunotherapeutics. But this vaccine still has to be tested in a new trial early next year before its submission for marketing authorization in the year 2027.

The information shared in this blog is for educational purposes only.

Subscribe to our newsletter or follow us on Facebook or Twitter today and never miss out an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,322)
  • Lung Cancer: Symptoms and Treatment (5,651)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025
  • Lung Cancer Screening Is Beneficial For Non-Smokers As Well April 28, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d